Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 172
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT04718389 | A Study of GSK3511294 (Depemokimab) Compared With Mepolizumab or Benralizumab in Participants With Severe Asthma With an Eosinophilic Phenotype | ||
| NCT06549946 | Ixovex-1 Single Agent and Combination Therapy | ||
| NCT05110261 | Evaluate the Safety and Efficacy of Nirsevimab in Healthy Preterm and Term Infants in China | ||
| NCT05872035 | Smartphone Enabled Hearing Study | ||
| NCT05267613 | Endoscopic Evidence of Maintenance of Healing With Oral NEXIUM in Patients 1 to 11 Years Old With Erosive Esophagitis. | ||
| NCT06485674 | Long-Term Organ Damage: Anifrolumab Versus Real-World Standard of Care in Adult Patients With Active Systemic Lupus Erythematosus | ||
| NCT04625972 | Phase III Double-blind, Placebo-controlled Study of AZD7442 for Post- Exposure Prophylaxis of COVID-19 in Adults | ||
| NCT07517445 | Bactericidal Activity and Safety of Nicotinamide in Combination With Bedaquiline, Pretomanid, and Linezolid in Drug-susceptible Pulmonary Tuberculosis | ||
| NCT03767075 | A Modular Multi-Basket Trial to Improve Personalized Medicine in Cancer Patients (Basket of Baskets) | ||
| NCT03120949 | Efficacy and Safety of Olokizumab in Subjects With Moderately to Severely Active Rheumatoid Arthritis | ||
| NCT05904938 | Oral Administration of Actitan-F in Paediatric Diarrhoea | ||
| NCT06073652 | Starter Infant Formula With Synbiotics | ||
| NCT05835349 | Observational Study of Venus P-Valve | ||
| NCT06559891 | THRIVE- THerapeutic IntravasculaR Ultrasound (TIVUS™) REnal Denervation System Versus Sham for the Adjunctive Treatment of Hypertension | ||
| NCT04840849 | Evaluate the Pharmacokinetics, Safety, and Tolerability of Nirsevimab in Healthy Chinese Adults | ||
| NCT04143503 | Observational Cohort Study on the Use of Parenteral Nutrition and Clinical Outcomes in Adult Critically Ill Patients | ||
| NCT05985083 | A Study Of IMM47 In Subjects With Advanced Solid Tumors | ||
| NCT02104817 | Outcomes Study to Assess STatin Residual Risk Reduction With EpaNova in HiGh CV Risk PatienTs With Hypertriglyceridemia | ||
| NCT04568031 | Study of AZD1222 for the Prevention of COVID-19 in Japan | ||
| NCT02374450 | A Surveillance Study of Diseases Specified as Adverse Events of Special Interest, of Other Adverse Events Leading to Hospitalisation or Death, and of Meningitis in Children in Africa Prior to Implementation of the RTS,S/AS01E Candidate Vaccine | ||
| NCT04612725 | A Study to Investigate the Use of Benralizumab in Patients With Chronic Spontaneous Urticaria Who Are Symptomatic Despite the Use of Antihistamines (ARROYO) | ||
| NCT03553108 | A Study Using Olaparib Tablets for Subjects With Advanced Solid Tumours. | ||
| NCT04605094 | Efficacy and Safety Study of the Use of Benralizumab for Patients With Moderate to Severe Atopic Dermatitis | ||
| NCT04535986 | A Phase 3 Clinical Trial to Evaluate the Safety and Efficacy of Ensifentrine in Patients With COPD | ||
| NCT05637515 | Hulio Interchangeability to Humira®, Comparing Pharmacokinetics, Efficacy, Safety and Immunogenicity | ||
| NCT04540393 | AZD1222 Vaccine for the Prevention of COVID-19 | ||
| NCT02734004 | A Phase I/II Study of MEDI4736 in Combination With Olaparib in Patients With Advanced Solid Tumors. | ||
| NCT06412250 | A Multicenter Observational Registry to Evaluate Safety and Performance of Vivo ISAR (SECURE Global Registry) | ||
| NCT03956355 | Tapinarof for the Treatment of Plaque Psoriasis in Adults (3001) | ||
| NCT05508750 | Growth and Safety Clinical Trial on a New Infant Formula | ||
| NCT04206917 | MultiPulse Therapy (MPT) for AF | ||
| NCT03649152 | Safety and Effectiveness of Propagermanium in Focal Segmental Glomerulosclerosis Participants Receiving Irbesartan | ||
| NCT04498117 | Oregovomab Plus Chemo in Newly Diagnosed Patients With Advanced Epithelial Ovarian Cancer Following Optimal Debulking Surgery | ||
| NCT07525427 | Bactericidal Activity of TBD09 in Combination With Other Drugs in Pulmonary Tuberculosis | ||
| NCT03254446 | Safety and Efficacy Study of TRC150094 to Improve the CV Risk in Subjects With Diabetes, Dyslipidemia and Hypertension | ||
| NCT04641481 | An Efficacy and Safety Clinical Trial of an Investigational COVID-19 Vaccine (BBV152) in Adult Volunteers | ||
| NCT05856266 | An 18-month Low-interventional Study to Assess Joint Health in Haemophilia A and B Patients on Prophylaxis With Efmoroctocog Alfa or Eftrenonacog Alfa | ||
| NCT03544281 | To Evaluate Safety, Tolerability, and Clinical Activity of the Antibody-drug Conjugate, GSK2857916 Administered in Combination With Lenalidomide Plus Dexamethasone (Arm A), or in Combination With Bortezomib Plus Dexamethasone (Arm B) in Participants With Relapsed/Refractory Multiple Myeloma (RRMM) | ||
| NCT04247581 | ECG App Algorithms Clinical Validation Study | ||
| NCT04376554 | Effect of Tebipenem on Normal Human Intestinal Microbiota | ||
| NCT06951867 | Tezspire Cardiac Events PASS | ||
| NCT04123574 | A Pilot Study of BXCL701 in Patients With Pancreatic Cancer | ||
| NCT03850509 | Efficacy and Safety of Oral OPS-2071 in Participants With Crohn's Disease Showing Symptoms of Active Inflammation | ||
| NCT05310734 | PK and Safety Study of Natroba Topical Suspension 0.9% in Subjects 1 Month to 3 Years 11 Months of Age With Scabies | ||
| NCT03721263 | Study of ASLAN004 in Healthy Subjects | ||
| NCT04542057 | A Phase 3 Trial to Evaluate the Safety and Efficacy of Ensifentrine in Patients With COPD | ||
| NCT05055921 | MultiPulse Therapy (MPT) for AF (US) | ||
| NCT04188574 | A Trial Involving Treatment of BB2603 in Subjects With Distal Subungual Onychomycosis of the Toenail | ||
| NCT05970263 | IKANOS: Breztri Maintenance Versus Any Non-Triple Inhaled Therapy After Hospitalization for a COPD Exacerbation in the US | ||
| NCT05843916 | Switch Over Study of Biosimilar Agalsidase Beta for Fabry Disease |
